Somatic Mutational Analysis by Exome Sequencing Endometrial Carcinosarcomas
Demographics (1)
- sex - Gender of participant (phv00264787.v1.p1)
Other (15)
- AFFECTION_STATUS - Case control status of the subject (phv00264782.v1.p1)
- ANALYTE TYPE - Analyte type (phv00264790.v1.p1)
- BODY SITE - Body site where sample was collected (phv00264789.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00264781.v1.p1)
- HISTOLOGICAL TYPE - Cell or tissue type or subtype of sample (phv00264792.v1.p1)
- IS_TUMOR - Tumor status (phv00264791.v1.p1)
- PRIMARY TUMOR LOCATION - Primary tumor location (phv00264794.v1.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00264793.v1.p1)
- SAMPLE_ID - De-identified sample ID (phv00264788.v1.p1)
- SAMPLE_ID - Sample ID (phv00264784.v1.p1)
- SAMPLE_USE - Sample Use (phv00264785.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00264795.v1.p1)
- SUBJECT_ID - Subject ID (phv00264780.v1.p1)
- SUBJECT_ID - Subject ID (phv00264783.v1.p1)
- SUBJECT_ID - De-identified subject ID (phv00264786.v1.p1)